未登录

J

José João Mansure

McGill University

H指数:20

被引数:1,395

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The clinical relevance of tertiary lymphoid structures in assessing treatment response in muscle invasive bladder cancer

三级淋巴结构在评估肌层浸润性膀胱癌治疗反应中的临床意义

International Journal of Radiation Oncology*Biology*Physics

IF0

2025-10-220

OAAI

Improved Prediction of Trimodality Therapy Response in Muscle-Invasive Bladder Cancer Using Deep Learning and Pathology-Optimized Expansion Microscopy

Microscopy and Microanalysis

IF3

2025-07-250

PRE

Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model

CANCER BIOLOGY & THERAPY

IF4.6

2024-06-110

OAAI

Improving response to bladder-sparing therapies by combining radiotherapy to immuno-potentiating agents in immunologically cold models of bladder cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Gut microbial drivers of response to bladder-sparing therapy in human muscle-invasive bladder cancer enhance immunotherapy efficacy and limit immunosuppression following fecal microbiome transplantation in vivo

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Integrating novel immunotherapeutic approaches in organ-preserving therapies for bladder cancer

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2024-01-160

PRE

Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy

EUROPEAN UROLOGY OPEN SCIENCE

IF4.5

2023-11-011

OAAI

Exploring the impact of microbiome in the response of combined radiation with immune checkpoint blockade in muscle invasive bladder cancer (MIBC)

CANCER RESEARCH

IF16.6

2023-04-040

PRE

The predictive power of tertiary lymphoid structures in assessing response to trimodal therapy in muscle invasive bladder cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy

EUROPEAN UROLOGY OPEN SCIENCE

IF4.5

2022-02-018

OAAI

Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2021-07-0131

PRE

Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer

中性粒细胞胞外诱捕网在浸润性膀胱癌放射抵抗中的作用

NATURE COMMUNICATIONS

IF15.7

2021-05-13124

OAAI

PD-1/PD-L1 Immune Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects

MOLECULAR CANCER THERAPEUTICS

IF5.5

2020-01-0343

OAAI

Neutrophil extracellular traps and their implication with radioresistance in muscle invasive bladder cancer

CANCER RESEARCH

IF16.6

2019-07-011

PRE

The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance

SCIENTIFIC REPORTS

IF3.9

2019-04-2318

OAAI

Prognostic factors for progression in atypical meningioma

JOURNAL OF NEUROSURGERY

IF3.6

2018-11-0144

OAAI

Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma

MODERN PATHOLOGY

IF5.5

2018-08-0118

OAAI

Exploring the in situ expression of vascular endothelial growth factor and endoglin in pemphigus foliaceus variants and pemphigus vulgaris

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2018-04-064

PREAI

Cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Post-operative radiation therapy in atypical meningiomas: analysis of prognostic factors

RADIOTHERAPY AND ONCOLOGY

IF5.3

2017-05-010

OAAI